347 Results

People

  1. Mauro
    Mauro
  2. Clarkson
    Clarkson
  3. Berman
    Berman
  4. O'Reilly
    O'Reilly
  5. Strife
    Strife
  6. Wisniewski
    Wisniewski
  7. Kernan
    Kernan
  8. Sawyers
    Sawyers
  9. Scheinberg
    Scheinberg
  10. Papadopoulos
    Papadopoulos

Groups

  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (207)
  3. Center for Hematologic Malignancies (182)
  4. Adult Leukemia (117)
  5. Sloan Kettering Institute Faculty (108)
  6. GSK Faculty (106)
  7. Tow Center for Developmental Oncology (TCDO) (77)
  8. Molecular Pharmacology and Chemistry Program Faculty (71)
  9. Human Oncology and Pathogenesis Program (47)
  10. Pediatrics, Department of (46)
  1. "chronic myeloid leukemia"
Formats
  1. Journal Article (300)
  2. Meeting Abstract (18)
  3. Review (10)
  4. Conference Paper (8)
  5. Research Letter (6)
  6. Correspondence (2)
  7. Editorial (2)
  8. Guidelines (1)
Groups
  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (207)
  3. Center for Hematologic Malignancies (182)
  4. Adult Leukemia (117)
  5. Sloan Kettering Institute Faculty (108)
  6. GSK Faculty (106)

More Groups

People
  1. Michael Mauro (56)
  2. Bayard Clarkson (40)
  3. Ellin Berman (24)
  4. Annabel Strife (20)
  5. Richard O'Reilly (20)
  6. David Wisniewski (18)

More People

Years
  1. 2025 (7)
  2. 2024 (16)
  3. 2023 (20)
  4. 2022 (13)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Blood (29)
  2. Leukemia (23)
  3. Clinical Lymphoma, Myeloma and Leukemia (19)
  4. Biology of Blood and Marrow Transplantation (17)
  5. Bone Marrow Transplantation (15)
  6. Cancer Research (14)

More Publications

Publishers
  1. Elsevier Inc. (51)
  2. Nature Publishing Group (51)
  3. American Society of Hematology (33)
  4. American Association for Cancer Research (20)
  5. John Wiley & Sons (12)
  6. Springer (12)

More Publishers

Results (347)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CML and the WHO: Why?
    Editorial

    Berman, E.; Shah, N. P.; Deninger, M.; Altman, J. K.; Amaya, M.; Begna, K.; Bhatia, R.; Chan, O.; Collins, R.; Curtin, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer
    Journal Article

    Stonestrom, A. J.; Menghrajani, K. N.; Devlin, S. M.; Franch-Expósito, S.; Ptashkin, R. N.; Patel, S. Y.; Spitzer, B.; Wu, X.; Jee, J.; Vela, P. S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Longitudinal clinical data improve survival prediction after hematopoietic cell transplantation using machine learning
    Journal Article

    Zhou, Y.; Smith, J.; Keerthi, D.; Li, C.; Sun, Y.; Mothi, S. S.; Shyr, D. C.; Spitzer, B.; Harris, A.; Chatterjee, A.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution
    Review

    Santinelli, E.; Pascale, M. R.; Xie, Z.; Badar, T.; Stahl, M. F.; Bewersdorf, J. P.; Gurnari, C.; Zeidan, A. M.
    Blood Reviews (2023)

    Fulltext@MSK | Save
  • Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: Final report of BMT CTN 2002
    Research Letter

    Meyers, G.; Hamadani, M.; Martens, M.; Ali, H.; Chevallier, P.; Choe, H.; Harris, A. C.; Holler, E.; van Hooren, E.; Klaassen, W.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Estimated savings after stopping tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia
    Journal Article

    Winn, A. N.; Atallah, E.; Cortes, J.; Deininger, M. W. N.; Kota, V.; Larson, R. A.; Moore, J. O.; Mauro, M. J.; Oehler, V. G.; Pinilla-Ibarz, J.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • First-in-human phase I study of ELVN-001, an oral, selective BCR::ABL1 tyrosine kinase inhibitor, in patients with chronic myeloid leukemia who failed prior tyrosine kinase inhibitors
    Meeting Abstract

    Mauro, M.; Lang, F. B.; Kim, D. W.; Heinrich, M.; Sasaki, K.; Lyssikatos, J.; Collins, H.; Hochhaus, A.
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • ASC2ESCALATE: A US, phase II open-label, single-arm, dose-escalation study of asciminib monotherapy in second-line (2L) and first-line (1L) treatment of patients with chronic myeloid leukemia in chronic phase (CML-CP)
    Meeting Abstract

    Atallah, E.; Mauro, M.; Sasaki, K.; Levy, M.; Koller, P.; Yang, D.; Laine, D.; Sabo, J.; Gu, E. N.; Cortes, J.
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Treatment-free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5-year analysis of DASFREE
    Journal Article

    Shah, N. P.; García-Gutiérrez, V.; Jiménez-Velasco, A.; Larson, S. M.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Mauro, M. J.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients
    Journal Article

    Troullioud Lucas, A. G.; Boelens, J. J.; Prockop, S. E.; Curran, K. J.; Bresters, D.; Kollen, W.; Versluys, B.; Bierings, M. B.; Archer, A.; Davis, E.; more...
    Frontiers in Oncology (2023)

    Fulltext@MSK | Save